Sign in
4

Changes in Ownership

Enliven Therapeutics, Inc. Filed Acc 0001209191-22-009391

Director bought 31,826 shares at an average $1.23 ($39,246)

From the SEC's structured data for this filing

Trades in this filing

MOTT DAVID M · Director

Table I: Non-derivative

3 lines
Date Transaction Shares Price Value Owned after D/I
2022-02-10 Purchase : show line 1 in the form +8,753 $1.29 $11,291 8,753 D
2022-02-11 Purchase : show line 2 in the form +14,573 $1.23 $17,925 23,326 D
2022-02-14 Purchase : show line 3 in the form +8,500 $1.18 $10,030 31,826 D
Open-market purchases · 31,826 sh · avg $1.23 · $39,246
Loading xslF345X03/doc4.xml…